Asthma Control and Clinical Practice in Hungary 2009

AstraZeneca

Status: Completed

Conditions: Asthma Control Level

Study type: Observational

Funder types: Industry

Identifiers

NCT00900861

NIS-RHU-DUM-2009/1

Details and patient eligibility

About

A prospective study led amongst pulmonologists. Patients asthma control level will be evaluated based on GINA guideline criteria. HRQoL measured by Visual analogue scale. Clinical practice: non controlled patients therapy assessed.

Enrollment: 3,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Asthma patients treated with ICS or bronchodilators

Exclusion criteria

• COPD
• pulmonary cancer
• pulmonary tuberculosis

Trial design

3,000 participants in 1 patient group

1

Description:

Asthmatic patients above 18 y, treated with ICS or bronchodilators